All In Biotech

Free tool

FAERS Monitor: Hulio

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761154 or its brand name (Hulio, Adalimumab-Fkjp). Reports on generic versions are filed under their own applications.

Reports

45,917

Serious

43,644

95% of reports

Hospitalization

16,237

Death reported

6,967

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective10,540
  • off label use8,523
  • rheumatoid arthritis5,848
  • fatigue5,533
  • pain5,476
  • arthralgia5,246
  • rash4,727
  • condition aggravated4,537
  • drug intolerance4,342
  • systemic lupus erythematosus4,215
  • joint swelling4,122
  • diarrhoea4,107
  • nausea4,106
  • headache4,071
  • treatment failure4,010

Reports by year received

View as table
YearReports
20048
200525
200610
200744
2008136
2009138
2010257
2011208
2012256
2013295
2014277
2015317
2016504
2017725
20181,253
20192,032
20202,712
20213,238
20224,580
20236,718
20248,378
20258,205
20265,601

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,008,242 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
systemic lupus erythematosusSignal4,21561.659.7221,737
rheumatoid arthritisSignal5,84824.824.2127,478
treatment failureSignal4,01023.222.681,548
drug intoleranceSignal4,34221.520.981,454
joint swellingSignal4,12216.215.756,931
condition aggravatedSignal4,5376.96.722,978
arthralgiaSignal5,2465.85.721,194
rashSignal4,7275.04.915,325
off label useSignal8,5234.54.423,908
painSignal5,4764.14.013,159
drug ineffectiveSignal10,5403.73.621,818
fatigueSignal5,5333.33.28,995
headacheSignal4,0713.02.95,509
diarrhoeaSignal4,1072.92.85,338
nauseaSignal4,1062.42.33,407

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.